CAR T-cell therapy in multiple myeloma: more room for improvement
10.1038/s41408-021-00469-5
Saved in:
Main Authors: | Teoh, Phaik Ju, Chng, Wee Joo |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Review |
Language: | English |
Published: |
SPRINGERNATURE
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206180 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
by: Zhang, X, et al.
Published: (2022) -
CD28 CO-STIMULATION AND CANCER IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR-MODIFIED NATURAL KILLER CELLS
by: YANG CHIYUN
Published: (2018) -
Electroporation of NKG2D RNA CAR Improves V?9V?2 T Cell Responses against Human Solid Tumor Xenografts
by: Ang, W.X., et al.
Published: (2021) -
IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY
by: NATASHA VINANICA
Published: (2020) -
Targeting car to the peptide?mhc complex reveals distinct signaling compared to that of tcr in a jurkat t cell model
by: Wu, Ling, et al.
Published: (2022)